Vincent J. Angotti Acelrx Pharmaceuticals Inc (ACRX) insider trading activity

Vincent J. Angotti is CHIEF EXECUTIVE OFFICER of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 198,066 shares of ACRX, which is worth approximately $223,814. The most recent transaction as insider was on Aug 30, 2024, when has been sold 7,260 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $7,623. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 198K

9.55% 3M change

115.75% 12M change

Total Value Held $223,814

Vincent J. Angotti Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 30 2024	BUY Open market or private purchase	$7,623 $1.05 p/Share	7,260 Added 3.54%	198,066 Common Stock
Jun 14 2024	BUY Open market or private purchase	$1,408 $1.08 p/Share	1,304 Added 0.72%	180,806 Common Stock
Jun 13 2024	BUY Open market or private purchase	$4,432 $0.97 p/Share	4,570 Added 2.48%	179,502 Common Stock
Jun 12 2024	BUY Open market or private purchase	$4,002 $0.97 p/Share	4,126 Added 2.3%	174,932 Common Stock
Mar 12 2024	BUY Grant, award, or other acquisition	$8,960 $1.12 p/Share	8,000 Added 4.47%	170,806 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	$1,120 $1.12 p/Share	1,000 Added 0.61%	162,806 Common Stock
Mar 03 2024	SELL Payment of exercise price or tax liability	$2,109 $1.3 p/Share	1,623 Reduced 0.99%	161,806 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	58,667 Added 27.66%	153,429 Common Stock
Feb 11 2024	SELL Payment of exercise price or tax liability	$4,095 $1.1 p/Share	3,723 Reduced 3.78%	94,762 Common Stock
Feb 10 2024	SELL Payment of exercise price or tax liability	$3,652 $1.1 p/Share	3,320 Reduced 3.26%	98,485 Common Stock
Dec 13 2023	BUY Open market or private purchase	$7,300 $0.73 p/Share	10,000 Added 8.94%	101,805 Common Stock
Sep 11 2023	BUY Open market or private purchase	$8,000 $0.8 p/Share	10,000 Added 9.82%	91,805 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$2,230 $1.31 p/Share	1,703 Reduced 2.6%	63,836 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$5,579 $1.68 p/Share	3,321 Reduced 4.82%	65,539 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	19,500 Added 22.07%	68,860 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$4,003 $2.02 p/Share	1,982 Reduced 3.86%	49,360 Common Stock
Jun 07 2022	BUY Open market or private purchase	$10,208 $0.22 p/Share	46,400 Added 4.36%	1,016,919 Common Stock
Mar 03 2022	SELL Payment of exercise price or tax liability	$9,451 $0.41 p/Share	23,051 Reduced 2.32%	970,519 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$9,223 $0.4 p/Share	23,058 Reduced 2.29%	983,570 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	390,000 Added 27.92%	1,006,628 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$11,747 $0.43 p/Share	27,318 Reduced 4.24%	616,628 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	200,000 Added 23.9%	636,980 Common Stock
Feb 11 2021	SELL Payment of exercise price or tax liability	$60,627 $2.63 p/Share	23,052 Reduced 5.11%	427,887 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$64,903 $2.59 p/Share	25,059 Reduced 5.26%	450,939 Common Stock

VJA

Vincent J. Angotti

CHIEF EXECUTIVE OFFICER

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Value

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX

Account